FDA Approved New Gene Test can Help Some Breast Cancer Patients Avoid Chemo

by Shirley Johanna on May 28, 2015 at 6:41 PM
Font : A-A+

FDA Approved New Gene Test can Help Some Breast Cancer Patients Avoid Chemo

A new gene test can help oncologists by providing deeper insights into tumors and reduce the use of unnecessary chemotherapy for some breast cancer patients.

Launched by genetics and genomics company ILife Discoveries in the capital on May 21, the new "MammaPrint & Blueprint" test will help evaluate the risk of distant recurrence of breast cancer.


It will help oncologists in identifying patients who can safely forego chemotherapy.

"The test can help doctors reduce the use of unnecessary chemotherapy by identifying the risks and its need," Anand Gupta, founder of iLife Discoveries, said in a statement.

Not all cancers have the same physiology nor do all tumors follow the same path of development.

MammaPrint is a 70-gene assay intended as a prognostic test for women of all ages.

According to Ramesh Sarin, senior consultant (surgical oncology) at Indraprastha Apollo Hospitals, with an FDA approved 70 gene-Mammaprint test now available, "we can predict the behavior of tumor by looking at its genomic profiling and manage the patient accordingly".

Blueprint is a molecular assay used in addition to the MammaPrint test in a target population of patients with early stage (stage I or II) breast cancer.

By identifying the breast cancer subtype, BluePrint allows determination of a patient's potential level of responsiveness to chemotherapy more accurately as compared to currently available technologies, with better correlation to long-term clinical treatment outcomes.

"Blueprint along with MammaPrint helps us to pick and choose a proper treatment for the patient based on their specific functional subtype and overall risk of recurrence," said Ajay Sharma, medical oncologist at Rajiv Gandhi Cancer Hospital.

Through the gene test results, patients are stratified into two distinct groups - low risk (good prognosis) or high risk (poor prognosis) of distant recurrence.

Unlike other tests, the patient is given definitive "low risk" and "high risk" results, eliminating the uncertainty of an intermediate risk score which can affect up to 39 percent of patients tested, the statement added.

Source: Medindia

News A-Z
News Category
What's New on Medindia
World Alzheimer's Day 2021 - 'Know Dementia, Know Alzheimer's
'Hybrid Immunity' may Help Elude COVID-19 Pandemic
Stroop Effect
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Women and Cancer DNA Finger Printing Breast Biopsy Pagets disease of the breast Mastitis Cancer and Homeopathy Breast Cancer Facts Cancer Facts Cancer Tattoos A Body Art 

Recommended Reading
Breast Cancer Screening using Mammogram
Breast cancer if detected early can be completely cured. Mammography is used to screen women for ......
Breast Cancer Management: Advances
The crab that invades the breast is no more a fear factor with all the advancements that medical ......
Gene Test Successfully Speeds Up Cancer Treatment
A wide-ranging genetic test for mutations in cancer cells to help finetune treatment for patients .....
Oncologists Differ Widely When It Comes to Offering Cancer Gene Testing
As an assessment of physician's attitude towards the rollout of the tumor profiling project called ...
Breast Biopsy
Breast biopsy involves removing a sample of breast tissue to determine whether it is cancerous or .....
DNA Finger Printing
DNA fingerprinting is a technique which helps forensic scientists and legal experts solve crimes, id...
Mastitis is a common cause of tenderness, swelling and pain in breast, owing to inflammation in the ...
Pagets disease of the breast
A detailed description of the Paget's disease of the breast, characteristic signs and symptoms, dete...
Tattoos A Body Art
Tattoos are a rage among college students who sport it for the ‘cool dude’ or ‘cool babe’ look...
Women and Cancer
Cancer is one of the frequently talked about and most feared disease that falls under the genre of l...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use